InsiderClue
← All stocks

Incyte

INCY Net buying
CIK 0000879169 #251 in the set updated 17 Sep 2026
Bought (120 mo)
$302.00M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$244.18M
$53.43M on a plan · $162.91M straight out of an exercise
Sold at will
$27.84M
48 of 301 sales
Net
+$57.82M
+$274.16M against sales at will

By person

39 insiders · 401 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BAKER BROS. ADVISORS LP entity
Director
$299.55M (40)
—
+$299.55M
28,486,950
14.05%
$3.58B
−8.5%
Hoppenot Herve
Director
$1.91M (2)
$50.85M (6) scheduled
−$48.93M
326,803
0.1612%
$41.03M
−14.4%
Stein Steven H
CMO & Head of Late-Stage Dev.
—
$28.29M (35) scheduled
−$28.29M
30,916
0.0153%
$3.88M
+56.8%
FRIEDMAN PAUL A
Director
—
$24.72M (6) scheduled
−$24.72M
256,813
0.1267%
$32.25M
−9.1%
SWAIN PAULA J
EVP, Human Resources
—
$23.07M (29) scheduled
−$23.07M
106,482
0.0525%
$13.37M
+264.1%
Flannelly Barry P
EVP & General Manager US
—
$16.16M (34) scheduled
−$16.16M
35,149
0.0173%
$4.41M
+143.6%
Wenqing Yao
EVP, Head of Discovery Chem
—
$13.63M (13) scheduled
−$13.63M
98,575
0.0486%
$12.38M
−28.6%
CAGNONI PABLO J
President, Global Head of R&D
—
$11.30M (7) scheduled
−$11.30M
183,200
0.0904%
$23.00M
+1,016%
Pasquale Maria E
EVP & General Counsel
—
$9.67M (17) scheduled
−$9.67M
69,724
0.0344%
$8.75M
+7,554%
GRYSKA DAVID W
Executive Vice President, CFO
—
$9.18M (8) scheduled
−$9.18M
10,235
0.0050%
$1.29M
−46.2%
Trower Paul
Principal Accounting Officer
—
$8.64M (17) scheduled
−$8.64M
32,268
0.0159%
$4.05M
+151.7%
Iyengar Vijay K
EVP, GMAPPS
—
$8.24M (25) scheduled
−$8.24M
40,540
0.0200%
$5.09M
+401.1%
Morrissey Michael James
EVP, Head of Tech. Operations
—
$7.30M (4) scheduled
−$7.30M
34,065
0.0168%
$4.28M
−20.9%
DIXON WENDY L
Director
—
$6.81M (6) scheduled
−$6.81M
17,768
0.0088%
$2.23M
+112.1%
Mayes Patrick A
EVP & Chief Scientific Officer
—
$6.56M (15) scheduled
−$6.56M
61,441
0.0303%
$7.71M
−8.8%
Huber Reid M
EVP, Chief Scientific Officer
—
$4.28M (7)
−$4.28M
34,571
0.0171%
$4.34M
−49.9%
BROOKE PAUL A
Director
—
$2.96M (1) scheduled
−$2.96M
261,911
0.1292%
$32.89M
+33.4%
Denton Sheila A.
EVP & General Counsel
—
$2.14M (16) scheduled
−$2.14M
26,569
0.0131%
$3.34M
+3,950%
Dickinson Jonathan Elliott
EVP, General Manager, Europe
—
$2.02M (4)
−$2.02M
36,390
0.0180%
$4.57M
+36.1%
Dhanak Dashyant
EVP & Chief Scientific Officer
—
$1.87M (20) scheduled
−$1.87M
58,968
0.0291%
$7.40M
—
Siegel Eric H.
EVP, General Counsel
—
$1.75M (7) scheduled
−$1.75M
21,053
0.0104%
$2.64M
+43.0%
Tray Thomas
Principal Accounting Officer
—
$1.51M (17) scheduled
−$1.51M
21,699
0.0107%
$2.72M
+22.9%
Clancy Paul J
Director
—
$1.42M (1) scheduled
−$1.42M
25,635
0.0126%
$3.22M
—
Issa Mohamed Khairie
EVP, Head of U.S. Commercial
—
$1.31M (2) scheduled
−$1.31M
71,797
0.0354%
$9.01M
—
BIENAIME JEAN JACQUES
Director
$533.44K (7)
$212.89K (3)
+$320.55K
24,424
0.0120%
$3.07M
+3,064%
Heeson Lee
EVP, Head of Incyte Intl
—
$289.02K (1) scheduled
−$289.02K
38,041
0.0188%
$4.78M
—
BAKER JULIAN
Director
—
—
—
767,095
0.3784%
$96.32M
—
Meury William
Chief Executive Officer
—
—
—
183,129
0.0903%
$22.99M
—
Stamoulis Christiana
EVP & Chief Financial Officer
—
—
—
125,759
0.0620%
$15.79M
+6,346%
Upadhyay Suketu
EVP & Chief Financial Officer
—
—
—
26,343
0.0130%
$3.31M
—
HARRIGAN EDMUND
Director
—
—
—
23,019
0.0114%
$2.89M
—
FOUSE JACQUALYN A
Director
—
—
—
20,968
0.0103%
$2.63M
—
Hoffman Richard A.
EVP & General Counsel
—
—
—
16,861
0.0083%
$2.12M
—
Gardner David H
EVP, Chief Strategy Officer
—
—
—
16,824
0.0083%
$2.11M
—
High Katherine A
Director
—
—
—
14,983
0.0074%
$1.88M
—
Trotta Matteo
EVP, GM, Dermatology US
—
—
—
14,882
0.0073%
$1.87M
+3,593%
BRAWLEY OTIS W
Director
—
—
—
12,894
0.0064%
$1.62M
—
Basi Ramitpal K
EVP, Human Resources
—
—
—
10,993
0.0054%
$1.38M
—
Schaffert Susanne
Director
—
—
—
7,389
0.0036%
$927.76K
—

Individual transactions

26
Insider
Date
Role
Action
Shares
Price
Amount
SWAIN PAULA J
1 Sep 2023
EVP, Human Resources
Sell
8,449
$65.13
$550.28K
Dhanak Dashyant
26 Jan 2023
EVP & Chief Scientific Officer
Sell
2,419
$85.00
$205.62K
Stein Steven H
4 Jan 2023
EVP & Chief Medical Officer
Sell
28,399
$79.78
$2.27M
Tray Thomas
19 Dec 2022
Principal Accounting Officer
Sell
1,223
$82.16
$100.48K
Tray Thomas
22 Jul 2022
Principal Accounting Officer
Sell
1,564
$83.13
$130.02K
Flannelly Barry P
7 Jul 2022
EVP & General Manager US
Sell
2,873
$79.38
$228.06K
Iyengar Vijay K
7 Jul 2022
EVP, GMAPPS
Sell
5,787
$79.38
$459.37K
Dickinson Jonathan Elliott
31 Jan 2022
EVP, General Manager, Europe
Sell
7,375
$74.19
$547.15K
Dhanak Dashyant
1 Oct 2021
EVP & Chief Scientific Officer
Sell
389
$68.67
$26.71K
Dhanak Dashyant
1 Sep 2021
EVP & Chief Scientific Officer
Sell
388
$76.71
$29.76K
Dhanak Dashyant
2 Aug 2021
EVP & Chief Scientific Officer
Sell
389
$77.49
$30.14K
Iyengar Vijay K
29 Jul 2021
EVP GPS, BD, & Licensing
Sell
4,911
$78.29
$384.48K
Dhanak Dashyant
1 Jul 2021
EVP & Chief Scientific Officer
Sell
396
$84.09
$33.30K
Wenqing Yao
29 Jun 2021
EVP, Head of Discovery Chem
Sell
27,194
$85.37
$2.32M
Dhanak Dashyant
1 Jun 2021
EVP & Chief Scientific Officer
Sell
395
$84.13
$33.23K
Dhanak Dashyant
3 May 2021
EVP & Chief Scientific Officer
Sell
396
$85.40
$33.82K
Dhanak Dashyant
1 Apr 2021
EVP & Chief Scientific Officer
Sell
396
$81.57
$32.30K
Morrissey Michael James
29 Mar 2021
EVP, Head of Tech. Operations
Sell
20,000
$81.08
$1.62M
Dhanak Dashyant
1 Mar 2021
EVP & Chief Scientific Officer
Sell
395
$79.73
$31.49K
Flannelly Barry P
25 Jan 2021
EVP & General Manager US
Sell
2,744
$100.00
$274.40K
BIENAIME JEAN JACQUES
10 Nov 2020
Director
Sell
798
$83.00
$66.23K
Stein Steven H
16 Jul 2020
EVP & Chief Medical Officer
Sell
766
$103.83
$79.53K
Stein Steven H
8 Jul 2020
EVP & Chief Medical Officer
Sell
610
$108.56
$66.22K
Iyengar Vijay K
8 Jul 2020
EVP GPS, BD, & Licensing
Sell
475
$108.56
$51.57K
Iyengar Vijay K
7 Jul 2020
EVP GPS, BD, & Licensing
Sell
3,120
$107.98
$336.90K
Dickinson Jonathan Elliott
22 Jun 2020
EVP, General Manager, Europe
Sell
9,000
$105.31
$947.79K
Showing 250 of 401 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 919
Amendments (4/A) skipped 3
Filings about a different issuer 4
Unreadable filings 0
Joint filings 64
Sales on a Rule 10b5-1 plan 58
Sales straight out of an exercise 195
Sales at will 48
Transactions with no price 0
Shares from compensation/vesting 24,683,547
Sales filed before the plan box existed 47
History held since 26 Sep 2016